Suppr超能文献

人类白细胞抗原(HLA)-C特异性“激活型”或“抑制型”自然杀伤细胞受体具有高度同源的细胞外结构域,但跨膜和胞质部分有所不同。

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

作者信息

Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L

机构信息

Istituto Nazionale per la Ricerca sul Cancro e Centro Biotecnologie Avanzate, Genova, Italy.

出版信息

J Exp Med. 1996 Feb 1;183(2):645-50. doi: 10.1084/jem.183.2.645.

Abstract

Natural killer cells express clonally distributed receptors specific for major histocompatibility complex class I molecules. The human leukocyte antigen (HLA)-C-specific receptors have been molecularly identified and cloned. They exist not only as inhibitory (p58) but also as activatory (p50) receptors. Here we show that p50 and p58 are highly homologous in their extracellular regions formed by two Ig-like domains. In contrast, major differences exist in their transmembrane and cytoplasmic portions. Whereas p 58 displays a 76-84-amino acid cytoplasmic tail containing an unusual antigen receptor activation motif, p50 is characterized by a shorter 39-amino acid tail. In addition, whereas p58 has a nonpolar transmembrane portion, p50 contains the charged amino acid Lys. These data strongly suggest that receptors with identical HLA-C allele specificity can mediate functions of opposite sign owing to their different transmembrane/cytoplasmic portions.

摘要

自然杀伤细胞表达对主要组织相容性复合体I类分子具有特异性的克隆性分布受体。人类白细胞抗原(HLA)-C特异性受体已在分子水平上得到鉴定和克隆。它们不仅以抑制性(p58)受体形式存在,也以激活性(p50)受体形式存在。在此我们表明,p50和p58在由两个免疫球蛋白样结构域形成的细胞外区域高度同源。相反,它们的跨膜和细胞质部分存在重大差异。p58具有一个包含异常抗原受体激活基序的76 - 84个氨基酸的细胞质尾巴,而p50的特征是较短的39个氨基酸的尾巴。此外,p58有一个非极性跨膜部分,而p50含有带电荷的氨基酸赖氨酸。这些数据有力地表明,具有相同HLA - C等位基因特异性的受体因其不同的跨膜/细胞质部分可介导相反信号的功能。

相似文献

引用本文的文献

2
Natural killer cells in cancer immunotherapy.癌症免疫疗法中的自然杀伤细胞。
MedComm (2020). 2024 Jun 15;5(7):e626. doi: 10.1002/mco2.626. eCollection 2024 Jul.
3
4
Recurrent implantation failure: A comprehensive summary from etiology to treatment.反复种植失败:从病因到治疗的全面总结。
Front Endocrinol (Lausanne). 2023 Jan 5;13:1061766. doi: 10.3389/fendo.2022.1061766. eCollection 2022.
6
ERAP, KIR, and HLA-C Profile in Recurrent Implantation Failure.复发性种植失败患者的 ERAP、KIR 和 HLA-C 特征。
Front Immunol. 2021 Oct 22;12:755624. doi: 10.3389/fimmu.2021.755624. eCollection 2021.
10
The Role of Natural Killer Cells in Autoimmune Diseases.自然杀伤细胞在自身免疫性疾病中的作用。
Front Immunol. 2021 Feb 25;12:622306. doi: 10.3389/fimmu.2021.622306. eCollection 2021.

本文引用的文献

2
Signal transduction by lymphocyte antigen receptors.淋巴细胞抗原受体的信号转导
Cell. 1994 Jan 28;76(2):263-74. doi: 10.1016/0092-8674(94)90334-4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验